Nurexone Biologic Quote - NRX

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.74

Bid

0.72

Offer

0.74

Volume

143,200

0.67 Day's Range 0.74

0.185 52 Week Range 1.19

Market Cap

35.704M

Previous Close

0.66

Open

0.70

Last Trade

5000

0.74

Last Trade Time

05:20:22

Financial Volume

VWAP

Average Volume (3m)

63,315

Shares Outstanding

48,249,000

Dividend Yield

PE Ratio

-9.81

Earnings Per Share (EPS)

-0.08

Revenue

Net Profit

-3.64M

Sector

Miscellaneous Metal Ores,nec

Industry

Pharmaceutical Preparations

Website

www.nurexone.com

Headquarters

Toronto, Ontario, Can

Founded

2011

Nurexone Biologic Inc is listed in the Miscellaneous Metal Ores sector of the TSX Venture Exchange with ticker NRX. The last closing price for Nurexone Biologic was $0.66. Over the last year, Nurexone Biologic shares have traded in a share price range of $ 0.185 to $ 1.19.

Nurexone Biologic currently has 48,249,000 shares in issue. The market capitalisation of Nurexone Biologic is $35.70 million. Nurexone Biologic has a price to earnings ratio (PE ratio) of -9.81.

NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market

TORONTO and HAIFA, Israel, June 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development

TORONTO and HAIFA, Israel, June 21, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application

TORONTO and HAIFA, Israel, June 11, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders

TORONTO and HAIFA, Israel, June 04, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials

TORONTO and HAIFA, Israel, May 29, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company...

NurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive Strategic Collaborations

TORONTO and HAIFA, Israel, May 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

Shares of Biopharma Up After News of Uplisting

When firms uplist to a higher exchange, they gain visibility and greater access to investors. And today, news of a strategic expansion in the United States is sending shares of this biopharma To...

NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility

TORONTO and HAIFA, Israel, April 25, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company is pleased...

NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicine

TORONTO and HAIFA, Israel, April 19, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased...

Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies

For anyone with a spinal cord injury (SCI), time is of the essence. The typical treatment scenario involves immobilization and surgery as quickly as possible. After that, managing To read the full...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.06	8.82352941176	0.68	0.77	0.62	148542	0.71794143	CS
4	0.245	49.4949494949	0.495	0.87	0.46	135406	0.72128014	CS
12	0.06	8.82352941176	0.68	0.87	0.46	63315	0.67086729	CS
26	0.445	150.847457627	0.295	1.19	0.26	123833	0.75249896	CS
52	0.465	169.090909091	0.275	1.19	0.185	80869	0.73785422	CS
156	-0.06	-7.5	0.8	1.19	0.1	55160	0.70606922	CS
260	-0.06	-7.5	0.8	1.19	0.1	55160	0.70606922	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MTBMount Burgess Mining Nl	AUD 0.002 (100.00%)	995.02k
FRSOBForrestania Resources Ltd	AUD 0.008 (60.00%)	163.13k
MRQMRG Metals Ltd	AUD 0.0055 (57.14%)	76.18M
EELENRG Elements Ltd	AUD 0.003 (50.00%)	163.89k
FG1OFlynn Gold Limited	AUD 0.006 (50.00%)	300k
IBGOIronbark Zinc Limited	AUD 0.001 (-50.00%)	10.5M
GCRGolden Cross Resources Ltd	AUD 0.001 (-50.00%)	10.25k
RNXRenegade Exploration Limited	AUD 0.0095 (-36.67%)	49.93M
TX3Trinex Minerals Ltd	AUD 0.002 (-33.33%)	41.09k
AYMAustralia United Mining Limited	AUD 0.002 (-33.33%)	244.84k
MRQOMRG Metals Limited	AUD 0.001 (0.00%)	173.6M
AXPAXP Energy Limited	AUD 0.001 (-33.33%)	88.47M
MRQMRG Metals Ltd	AUD 0.0055 (57.14%)	76.18M
RNXRenegade Exploration Limited	AUD 0.0095 (-36.67%)	49.93M
PLSPilbara Minerals Limited	AUD 2.98 (-3.25%)	38.83M